PharmaVision's Drug Discovery and Development reports assess the influence that new scientific research, technologies, regulations and business strategies may have on refining the drug R&D process and help to contain the escalating costs associated with product development.
The reports identify market leaders, technology specialists and service providers that are at the forefront of drug R&D covering different aspects of the process from the discovery phase, preclinical and clinical development phases, registration and post-marketing surveillance to improve productivity and reduce drug attrition.